About

Publications While At HealthPartners

selected publications

Journal Article

DURATION-2: efficacy and safety of switching from maximum daily sitagliptin or pioglitazone to once-weekly exenatide. 

Diabetic Medicine. 2011

Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study. 

Lancet (London, England). 2008

Review

Exenatide once weekly for the treatment of type 2 diabetes [review]. 

Expert opinion on investigational drugs. 2009

Contact

full name

K. Taylor

Quick Info

 

Collaboration

Co-author network

Map of science